Home > News > Content
Micro-invasive Medical Equipment Market Change For Cross-border Mergers And Acquisitions
Oct 09, 2017

Wall Street applause erupted in 1998 when an American heart surgery company, Sofamor-danek, bought orthopaedic company for $3.5 billion across borders. The American company is now a great American. Today, a Chinese heart surgery company minimally Invasive medical treatment, the same Cross-border access to orthopaedics, the United States to buy Wright Joint business for $290 million. "When Hong Kong stocks listed companies minimally invasive medical treatment of the United States established orthopaedic company, the acquisition of related assets, the medical device industry mergers and acquisitions senior personage Lu Shihua, speech expressed a kind of great expectations.

On the night of 20th, minimally invasive medical treatment announced the signing of an agreement with Johnson, the United States to buy the Conor company. In this way, there is no way to avoid the change in the domestic medical device field.

Minimally invasive medical treatment of the attackers

January 20, the third big event in 2014: The same day, the company signed an agreement with Johnson, the United States to buy the latter's Conor company, to win its name of all the real assets (production and development equipment and large-scale manufacturing processes, etc.) and intellectual property, and obtain the considered company in the global scope of the coronary stent in the field of several major patents for free use, for the micro-invasive "Fire Eagle" stent to the international market has laid a good foundation.

A year ago, in a short span of two months, two Chinese orthopaedic companies and comfort companies were purchased by the United States Stryker and the US. The domestic orthopedic medical device industry ranked first, the second enterprise by foreign Giants acquisition, not only means that the domestic market has been the trend of foreign monopoly, but also as the industry is regarded as the most "no son" of the acquisition case.

Minimally invasive medical care has played a role in attacking the attackers. "Our efforts are to break the situation of foreign  oligopolistic markets and reduce the cost of health care for the entire community." "Minimally Invasive medical president Zhang said. Minimally Invasive medical Chief Technical Officer Rom 71 revealed that after the acquisition of the company, the company's knee products are expected to be introduced into the Chinese market after a year.

Local Market Change Bureau

China Medical and Materials Association released a recent "2013 Chinese Medicine Equipment Blue Book" that the overall level of Chinese medical devices and international advanced level of the gap is about 15, the domestic high-end medical devices mainly rely on imports, the amount of imports accounted for about 40% of the total market.

In the industry, minimally invasive medical care is considered to be one of the few local star companies to contend with foreign giants. Its ability to enforce cross-border aspects has changed the valuations of capital markets. In a report, J.P. Morgan said that minimally invasive medical treatment to complete the acquisition of orthopaedic reconstruction business assets, is expected to generate $257 million in sales, compared to the 2013 Full-year forecast sales of 1.168 billion yuan higher than 33%, so the company's stock prices raised.

For minimally invasive medical care, the acquisition of the White Company's joint reconstruction business will enable the company to provide a full portfolio of products in the four major orthopedic markets of the hip, knee, spine and trauma sectors. "And the company's share of the proceeds from drug-eluting stents will be reduced from about 80% to 36%, and the Chinese market will go global by about 95% per cent to the 35% after the acquisition, in terms of regional earnings." ”

At present, in the field of implantable medical devices, le PU medical treatment in a-share listing, minimally invasive medical treatment in H-shares listed, Jiwei by H-shares listed companies in Shandong Province, two companies holding. "The lack of an international vision of the distribution of integrated medical equipment enterprises." "The industry believes that this is because the international perspective has a threshold, the threshold is research and development." Only focus on the forefront of research and development, a company can go to the international possibility.

The industry is expected to trigger a new wave of medical device investment in China because of steady demand growth.